Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 3
1996 1
1999 1
2000 2
2005 1
2007 1
2008 2
2009 1
2016 1
2019 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool.
Veldhuyzen van Zanten SJ, Bradette M, Chiba N, Armstrong D, Barkun A, Flook N, Thomson A, Bursey F; Canadian Dyspepsia Working Group. Veldhuyzen van Zanten SJ, et al. Among authors: bradette m. Can J Gastroenterol. 2005 May;19(5):285-303. doi: 10.1155/2005/674607. Can J Gastroenterol. 2005. PMID: 15915244 Review.
Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study.
Wetwittayakhlang P, Golovics PA, Khoury AA, Ganni E, Hahn GD, Cohen A, Wyse J, Bradette M, Bessissow T, Afif W, Wild G, Bitton A, Lakatos PL. Wetwittayakhlang P, et al. Among authors: bradette m. J Gastrointestin Liver Dis. 2022 Dec 16;31(4):403-410. doi: 10.15403/jgld-4375. J Gastrointestin Liver Dis. 2022. PMID: 36535055 Free article.
Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.
Rubin DT, Bradette M, Gabalec L, Dobru D, Márquez J, Inglis S, Magee E, Solomon D, D'Haens G; Ulcerative Colitis Remission Study Group. Rubin DT, et al. Among authors: bradette m. J Crohns Colitis. 2016 Aug;10(8):925-33. doi: 10.1093/ecco-jcc/jjw049. Epub 2016 Feb 23. J Crohns Colitis. 2016. PMID: 26908939 Free PMC article. Clinical Trial.
Update from the Canadian Dyspepsia Working Group.
Veldhuyzen van Zanten SJ, Flook N, Chiba N, Armstrong D, Barkun A, Bradette M, Thomson A, Bursey F, Blackshaw P, Frail D, Sinclair P. Veldhuyzen van Zanten SJ, et al. Among authors: bradette m. CMAJ. 2000 Sep 19;163(6):696. CMAJ. 2000. PMID: 11022579 Free PMC article. No abstract available.
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.
Feagan BG, Sandborn WJ, Mittmann U, Bar-Meir S, D'Haens G, Bradette M, Cohen A, Dallaire C, Ponich TP, McDonald JW, Hébuterne X, Paré P, Klvana P, Niv Y, Ardizzone S, Alexeeva O, Rostom A, Kiudelis G, Spleiss J, Gilgen D, Vandervoort MK, Wong CJ, Zou GY, Donner A, Rutgeerts P. Feagan BG, et al. Among authors: bradette m. JAMA. 2008 Apr 9;299(14):1690-7. doi: 10.1001/jama.299.14.1690. JAMA. 2008. PMID: 18398081 Clinical Trial.
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Zanten SJ, Bradette M, Farley A, Leddin D, Lind T, Unge P, Bayerdörffer E, Spiller RC, O'Morain C, Sipponen P, Wrangstadh M, Zeijlon L, Sinclair P. Zanten SJ, et al. Among authors: bradette m. Aliment Pharmacol Ther. 1999 Mar;13(3):289-95. doi: 10.1046/j.1365-2036.1999.00471.x. Aliment Pharmacol Ther. 1999. PMID: 10102960 Free article. Clinical Trial.
16 results